Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Drug metabolism and drug toxicity

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Inflammopharmacology

Adverse drug reactions are a major problem for both health care providers and the pharmaceutical industry. They are a common and significant cause of morbidity and mortality and occasionally result in the withdrawal of an otherwise valuable therapeutic agent. There is now overwhelming evidence that adverse drug reactions are often caused by a metabolite of the drug rather than the drug itself, and that idiosyncratic susceptibility is due to interindividual variability in (1) the initial metabolism of the drug, (2) the body's ability to resist the toxicity through up-regulation of defence and/or repair mechanisms and (3) the degree and type of involvement of the immune system. This review focuses on well characterised examples of adverse drug reactions, with an emphasis on those involving analgesics, and attempts to show how innovative approaches to their investigation have revealed novel pathways and mechanisms underlying their biochemical basis. Such data may provide new targets for the development of drugs to treat or protect individuals from adverse reactions to commonly used therapeutic agents.

Affiliations: 1: Department of Pharmacology & Therapeutics, University of Liverpool, PO Box 147, Liverpool, Merseyside, L69 3GE

10.1163/156856001300248461
/content/journals/10.1163/156856001300248461
dcterms_title,pub_keyword,dcterms_description,pub_author
6
3
Loading
Loading

Full text loading...

/content/journals/10.1163/156856001300248461
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/156856001300248461
Loading

Article metrics loading...

/content/journals/10.1163/156856001300248461
2001-05-31
2016-12-05

Sign-in

Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
     
    Inflammopharmacology — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation